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Background: Nutrition intake during growth strongly influences ovarian follicle development and egg laying in
chicken hens, yet the underlying endocrine regulatory mechanism is still poorly understood. The relevant research
progress is hindered by difficulties in detection of leptin gene and its expression in the chicken. However, a functional
leptin receptor (LEPR) is present in the chicken which has been implicated to play a regulatory role in ovarian follicle
development and egg laying. The present study targeted LEPR by immunizing against its extracellular domain (ECD),
and examined the resultant ovarian follicle development and egg-laying rate in chicken hens.
Methods: Hens that have been immunized four times with chicken LEPR ECD were assessed for their egg laying rate
and feed intake, numbers of ovarian follicles, gene expression profiles, serum lipid parameters, as well as STAT3
signaling pathway.
Results: Administrations of cLEPR ECD antigen resulted in marked reductions in laying rate that over time eventually
recovered to the levels exhibited by the Control hens. Together with the decrease in egg laying rate, cLEPR-immunized
hens also exhibited significant reductions in feed intake, plasma concentrations of glucose, triglyceride, high-density
lipoprotein, and low-density lipoprotein. Parallelled by reductions in feed intake, mRNA gene expression levels of AgRP,
orexin, and NPY were down regulated, but of POMC, MC4R and lepR up-regulated in Immunized hen hypothalamus.
cLEPR-immunization also promoted expressions of apoptotic genes such as caspase3 in theca and fas in granulosa layer,
but severely depressed IGF-I expression in both theca and granulosa layers.
Conclusions: Immunization against cLEPR ECD in egg-laying hens generated antibodies that mimic leptin bioactivity by
enhancing leptin receptor transduction. This up-regulated apoptotic gene expression in ovarian follicles, negatively
regulated the expression of genes that promote follicular development and hormone secretion, leading to follicle
atresia and interruption of egg laying. The inhibition of progesterone secretion due to failure of follicle development also
lowered feed intake. These results also demonstrate that immunization against cLEPR ECD may be utilized as a tool for
studying bio-functions of cLEPR.
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HensBackground
Leptin, secreted by the white adipocytes, plays important
roles in regulating appetite, metabolism and energy
homeostasis [1-3]. Leptin serves as a signal of the body
fat content or energy reserve [4,5] for the brain to re-
duce food intake [6,7], and for the peripheral tissues to
increase energy expenditure [1,8,9], and utilize the en-
ergy reserve and fat storage [10]. In addition, leptin is* Correspondence: zdshi@jaas.ac.cn
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unless otherwise stated.also instrumental to the initiation and the maintenance
of the reproductive activities through its action in the
hypothalamus to facilitate gonadotropin secretions
[4,11-14]. Leptin has also been reported to directly
antagonize ovarian estradiol and progesterone secretions
stimulated by gonadotrophin follicle stimulating hor-
mone (FSH) [15] or insulin-like growth factor I (IGF-I)
[16,17], thereby inhibiting ovarian follicle development.
Leptin has been reported to reduce cultured rat follicle
growth speed and granulosa cell numbers [18], and de-
creased luteinizing hormone (LH) induced ovulationsThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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served in chickens, as the ovarian follicle development is
often perturbed in overweight hens [20,21], and that lep-
tin has been observed to induce apoptosis of cultured
chicken granulosa cells [22]. Nevertheless, much contro-
versy exists over the presence of the chicken leptin gene
or its protein product [3,23-26]. Difficulties in detecting
leptin gene and products, together with the requirement
for large quantities of leptin hormone in the case of ad-
ministration studies, have hindered research into regula-
tion of reproductive activities by leptin in chicken hens.
Fortunately, the leptin receptor (lepR) gene is present
in the chicken genome [27,28] and its protein product,
the leptin receptor protein (LEPR), functions to mediate
hormone bioactivities [29]. For example, in vivo adminis-
trations of leptin from chicken and other species
depressed chick feed intake [7], blood triglyceride con-
centrations [30], and accelerated reproductive develop-
ment [31]. Furthermore, immunization against leptin
stimulated abdominal fat deposition and feed intake
[32]. These results of leptin administration and immuno-
neutralization should be mediated via LEPR signaling
channels.
Since hormones fulfill their regulatory roles through
the receptors, one could probe the signal transduction
mechanism of the hormone by employing specific bind-
ing molecules that mimic hormonal actions [33-36].
Therefore, leptin-mediated regulation of the chicken
ovarian follicular development could be studied by ma-
nipulating LEPR instead of using leptin directly. Previous
studies have demonstrated that immunization against re-
ceptor extracellular domains (ECDs) could produce both
anta- and agonistic effects [37], and that such a method
could be adopted to study endocrine regulation of
chicken ovarian follicular development [38]. The cLEPR
possesses a long ECD, extending up to 810 amino acid
residues [27]. Immunization against the domain prox-
imal to the cell membrane has showed to mimic leptin
signaling and reduced fat deposition in rats [unpublished
data], and weight loss in chickens [unpublished data]. In
the present study, we immunized the domain distal to
the membrane, or the N-terminal domain of LEPR, to
study its effects on ovarian follicle development in the
laying hens, in terms of egg-laying performance, follicu-
lar atresia, gene expression and feed intake.
Methods
Obligatory ethical approval
The experiment was approved by the Research Commit-
tee of Jiangsu Academy of Agricultural Sciences and
conducted with adherence to the Regulations for the Ad-
ministration of Affairs Concerning Experimental Ani-
mals (Decree No.2 of the State Science and Technology
Commission on November 14, 1988).Preparation of immunogens
A chicken LEPR ECD fusion protein, including a 36-
residue leading sequence derived from the expression
plasmid pRSETA (Invitrogen, Carlsbad, CA, USA), and
the 200-residue sequence spanning from the N-terminal
101st to 300th amino acid residue of cLEPR, was expres-
sed in E. coli strain BL21 (DE3). This cLEPR recombin-
ant protein which was 236 amino acid residues long was
purified to homogeneity by chromatography with Ni-NTA
resin (Qiagen). The pure protein was then dissolved in a
water /Grade 10 Injection white oil (Hangzhou Refinery,
Hangzhou, China) mixture (in volume, 40% water and
60% oil) to reach a final concentrations of 1 and 2 mg/mL.
The resulted emulsion was used as the immunogen in the
experiment. A bovine serum albumin (BSA) immunogen
was also prepared with the same method, with a final con-
centration of 1 mg/mL and 2 mg/mL.
Animals and treatments
Sixty Yuehuang hens, 152-day old, were equally allocated
into Control and cLEPR Immunized groups (each group
n = 30). The hens were kept individually in battery cages,
exposed to a 16 h light regime daily, and fed ad libitum
a laying diet of 18% crude protein and 11.33 MJ/kg
metabolizable energy. Egg laying was recorded daily at
17:00 and mean egg laying rate was calculated on a
weekly basis. On day 1 of the experiment, the Immu-
nized group was administered intramuscularly 1 ml
cLEPR immunogen containing 1 mg of the recombinant
cLEPR protein. Booster immunizations were performed
on day 21, 63 and 91 with 1ml cLEPR immunogen con-
taining 2 mg of the recombinant cLEPR protein. Simi-
larly, Control hens were treated with 1 ml BSA
immunogen on day 1 of the experiment and booster im-
munizations were performed on day 21, 63 and 91 with
1ml control immunogen containing 2 mg of the BSA.
During the experiment, blood samples were collected, at
2 week intervals, by venipuncture of wing veins from 12
birds in each group, into a syringe containing 100 IU of
heparin. The plasma was isolated by centrifugation at
1,000 g and stored at −20°C until analyzes until measure-
ments of antibody titer. Blood serums collected on d 35 of
the experiment were used for concentration measure-
ments of glucose, triglycerides, cholesterol, high-density
lipoprotein (HDL), low-density lipoprotein (LDL), and
very low-density lipoprotein (VLDL).
On day 95, when egg laying started to decrease again
in the Immunized cLEPR hens, all hens in each group
were slaughtered. Ovarian follicles were collected and
the numbers of large yellow follicles (LYF) and atretic
follicles were recorded. From the largest five LYFs (F1 to
F5) were granulosa and theca layers separated or iso-
lated. The isolates were frozen in liquid nitrogen and
subsequently stored under −70°C for gene expression
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lected, and snap frozen in liquid nitrogen.
Measurement of blood anti-cLEPR antibody titer
A standard enzyme linked immunosorbent assay (ELISA)
method was utilized to measure anti-cLEPR antibody ti-
ters in plasma. The recombinant cLEPR protein was used
to coat the 96-well microtiter plates (5 g /well in 250 L).
After blocking the plate with 1% skim milk and washing,
100 L of plasma sample, diluted 1:800 with 1% skimmed
milk, was added to each well and incubated with anti-
cLEPR antibody. The bound antibody was further labeled
by addition of horse radish peroxydase (HRP)-conjugated
sheep-anti-chicken antibody (Santa Cruz Biotechnology,
CA, USA). Detection of the bound antibody was initiated
by addition of chromogen tetraethyl benzidine (Sigma
Chemical Co, St Louis, USA) solution containing 0.03%
H2O2, and terminated with the addition of 2% H2SO4. Op-
tical absorbance at 450 nm, representing anti-cLEPR anti-
body titer, was measured. To overcome assay bias between
treatment groups, samples from each collection occasions
were measured on the same plate.
Western blotting
Liver tissue was homogenized and centrifuged. Approxi-
mately 30 μg of the supernatant was mixed with 2×
Laemmli buffer (Sigma-Aldrich Corp., Saint Louis, MO),
denatured, resolved on a denaturing PAGE, and trans-
ferred to a nitrocellulose membrane. The anti-stat3 and
anti-beta-actin primary antibodies (1:200, Cell Signaling
Technology, Inc., Boston, MA); and the anti-rabbit sec-
ondary antibody (1:50,000 Cell Signaling Technology,
Inc., Boston, MA) were used for detection. The signal
was developed using SuperSignal West-Pico kit (Thermo
Fisher Scientific, Waltham, MA).
Assays of serum glucose, triglycerides, cholesterol, HDL,
LDL and VLDL
Concentrations of glucose, triglycerides, cholesterol, HDL,
LDL, and VLDL were measured by using a ROCHE
Modular P800 Automatic Biochemical Analyzer (Roche
Diagnostics).
Measurements of gene expressions
Real-time quantitative PCR was performed for quantifi-
cation of β-actin, agouti-related peptide gene (AgRP),
neuropeptide Y (NPY), Proopiomelanocortin (POMC),
Melanocortin 4 receptor (MC4R), orexin, lepR, and go-
nadotrophin- releasing hormone I (GnRH-I) mRNA ex-
pression levels in the hypothalamus, LHβ and FSHβ in
pituitary gland, PPARγ in the abdominal fat tissue and
liver, FSHR, LHR, IGF-I, fas, caspase3, bcl2, steroidogenic
acute reguated protein (StAR), cytochrome P450, family19, subfamily A, polypeptide 1(CYP19A1), and cyto-
chrome P450, family 17, subfamily A, polypeptide 1
(CYP17A1) in ovarian granulosa and theca layers
(Table 1). Total RNA was extracted from each tissue
using Trizol (Invitrogen), and reverse transcribed to
cDNA using ReverTra Ace qPCR RT Kit (Toyobo,
Osaka, Japan). PCR reactions were carried out in a 50 μl
reaction volume with SYBR Green I Master Mix reagent
(Toyobo, Osaka, Japan) and 2.5 pmol specific primer pairs
shown in Table 1. An ABI PRISM_7500 sequence detec-
tion system (Applied Biosystems, Foster City, CA, USA)
was used to detect the amplification products. Upon com-
pletion of the real-time Q-PCR, threshold cycle (Ct, de-
fined as the cycle at which a statistically significant
increase in the magnitude of the signal generated by the
PCR reaction was first detected) values were calculated by
sequence detection software SDS Version 1.2.2 (Applied
Biosystems). The levels of gene expression were expressed
in the form of 2-△△Ct.
Statistical analysis
Differences between the Immunized and Control groups,
in terms of anti-cLEPR ECD antibody titer, feed intake,
the numbers of follicles, were analyzed by one-way ana-
lysis of variance. Differences of gene expression in hypo-
thalamus, pituitary gland, the abdominal fat tissue, liver,
and plasma concentrations of glucose, triglycerides, chol-
esterol, HDL, LDL, and VLDL were also analyzed by one-
way analysis of variance. The means were compared by
the LSD method. The data of gene expression in ovarian
granulosa and theca layers were analyzed using the mixed
model by SAS statistics software. The treatment group
and various sizes of ovarian follicles were designated as
fixed factors, while the hen identity was designated as the
random factor. The means were compared with least
squares means. All values are expressed as mean ± SEM.
All statistical analyses were performed with SAS software
Version 8.01 (SAS Institute Inc. Cary, NC. USA).
Results
Anti-cLEPR antibody titre
Antibody titers were measured by ELISA as optical
density (OD) value at 450 nm. Throughout the experi-
ment, the OD values were barely detectable in plasma
samples of the Control hens, which were considered to
be the non-specific binding of the assay. Fourteen days
after the primary immunization, the anti-cLEPR anti-
body titer had already increased (P < 0.05) above the
pre-immunized non-specific binding levels, and was fur-
ther increased following the second or 1st booster
immunization (P < 0.01). The titers in the Immunized
hens were maintained at high levels following the 2nd
and 3rd booster immunizations on day 63 and 91, re-
spectively (Figure 1A).
Table 1 Primers used in the real-time quantitative PCR of genes in chicken samples
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Throughout the entire experimental period, the daily egg-
laying rate in the Control hens remained relative stable,between 60% and 75%. However, in the Immunized hens,
the rate started to decrease from 68% at the beginning of
the experiment to approximately 55% around day 10
Figure 1 Changes of anti-cLEPR antibody titer, egg laying rate,
and feed intake between Control hens ( , n = 30) and cLEPR
Immunized hens ( , n = 30). (A) Changes of anti-cLEPR antibody
titer in hen plasma (B) Changes of egg laying rate (C) Changes of
feed intake. Vertical bars represent standard errors of the mean.
Asterisks indicate significant differences (*:P < 0.05, **:P < 0.01). Arrows
indicate administration of BSA and cLEPR immunogens and dose.
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(Figure 1B). The rate subsequently increase to the level
comparable to that in the Control group during the third
week of the experiment (P > 0.05). However, the rate
dropped sharply from the 4th week. After the first booster
immunization (cLEPR dose 2 mg/ml), the egg laying rate
went to a level below 45% and significantly lower (P < 0.01)
than the rate in the Control hens. The laying rate remained
depressed for further two weeks during the 5th and 6th
week of the experiment, before rising back to control levelsTable 2 Concentrations of total glucose, triglycerides, cholest
after the first booster immunization, mean ± SEM, mmol/L, n
Blood glucose triglyceride ch
Controls 14.088 ± 0.28a 17.1 ± 1.44a 4.9
cLEPR-immunized 12.97 ± 0.28b 12.07 ± 1.50c 4.0
Note: Means in the same column marked with different superscript letters differ sigagain at the 7th week of the experiment. The drops and re-
bounds of egg laying rate reappeared following the second
booster cLEPR immunization, albeit with smaller magni-
tude and shorter duration (Figure 1B). Finally, the 4th
cLEPR immunization brought about a small drop of egg
laying within five days before the hens were slaughtered
(Figure 1B).Feed intake during egg laying drop
Measured during the expected egg laying decrease, follow-
ing the first booster immunization, the feed intake of the
Control group slightly decreased to 115 g in the first week,
but thereafter gradually recovered to normal levels of 125 g
in the following three weeks. The post-immunization drop
of feed intake, however, was more marked in the Immu-
nized hens, which, by day 35 of the experiment, was below
105 g. As the laying rate started to rebound after day 35, so
did the feed intake, which recovered to the normal levels
exhibited by the Control hens (Figure 1C). The difference
in feed intake on day 35 was statistically significant between
the Control group (118.66 ± 3.99 g) and Immunized group
of chickens (101.97 ± 5.14 g, (P < 0.05)).Plasma metabolite concentrations
On day 35 of the experiment, i.e. when the egg laying
rate and feed intake were minimal in the Immunized
hens, after the first booster immunization, the plasma
concentrations of triglycerides and HDL in Immunized
cLEPR chickens were significantly lower than those in
the Control chickens (P < 0.01) (Table 2), as were the
concentrations of serum glucose and VLDL (p < 0.05).
On the other hand, the concentrations of LDL in Immu-
nized cLEPR chickens were significantly higher than in
the Control chickens (P < 0.05).Ovarian follicle numbers
On day 5 after the 3rd booster immunization with 2 mg
of cLEPR immunogen, the Immunized hens had lower
number of small yellow follicles (SYF) (P < 0.05), but
greater number of atretic follicles (P < 0.05), compared
to the Control hens (Table 3). Although the Immunized
hens also had fewer numbers of LYF and large white fol-
licle (LWF), compared to those of the Control hens, the
differences were not statistically significant (P > 0.05).erol, HDL, LDL, and VLDL in hens (sera collected on d 14
= 24)
olesterol HDL LDL VLDL
1 ± 0.43a 2.1 ± 0.40a 0.83 ± 0.08a 1.99 ± 0.26a
2 ± 0.34a 1.19 ± 0.08c 1.43 ± 0.16b 1.39 ± 0.25b
nificantly (a-b: P < 0.05; a-c: P < 0.01).
Table 3 Number of ovarian follicles counted on day 5
after the 4st administration (mean ± SEM,n = 8)
Types of follicles Controls Immunized
Large yellow follicles 4.2 ± 2.0a 2.4 ± 2.5a
Small yellow follicles 8.4 ± 2.6a 4.8 ± 1.8b
Large white follicles 19.2 ± 9.3a 14.8 ± 8.0a
Atretic follicle 0 ± 0a 4.0 ± 0.9b
Note: Values in the same row with different superscript letters differ
significantly (a-b, P < 0.05). Data are mean ± SEM (n = 8).
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On day 5 after the 3rd booster immunization, with 2 mg of
cLEPR immunogen, the cLEPR Immunized groups had 2-
fold increase of phosphorylated STAT3 proteins as quantified
by the Western blot analysis in the liver tissue homogenate
than in the Control group (Figure 2A and B) (P < 0.01).
Gene expression
Follicle development regulating genes
Following cLEPR immunization, the expressions of lepR
and caspase3 mRNA were strongly up- regulated in the
granulosa layer in the F1 to F5 follicles (P < 0.01), while
the expression level of fas was marginally but not statis-
tically (P > 0.05) significantly up-regulated. However, fas
expression was strongly up-regulated (P < 0.01) in the
theca layer in F1 to F3 follicles. On the contrary, the ex-
pression of bcl2 was slightly down-regulated in thecaFigure 2 Ratio of p-STAT3 protein/β-actin and levels of PPARγ mRNA
Immunized hens (■, n = 8). (A) Western blot of p-STAT3 (the band intens
ratios were used to analyze significant difference) (C) PPARγ mRNA expression
represent the standard errors of the mean. Means not marked by a commonand granulosa layers, with more significant decrease in
F5 and F2 follicles respectively (Figure 3).
The expressions of LHR, StAR, FSHR and IGF-I were
down-regulated (P < 0.05) following cLEPR immunization in
the granulosa layer in all class of follicles, and also in theca
layer for the latter two genes. In the theca layer, LHR expres-
sion was significantly lower (P < 0.05) in F5 follicle, but its
expression only dropped slightly in other larger follicles, in
cLEPR immunized hens. In the cases of CYP17A1 and
CYP19A1, expression in granulosa layer was down-
regulated in F1 follicles (P < 0.01 and P < 0.05 respectively).
Gonadotrophic hormone genes
The expressions of the GnRH-I gene in the hypothal-
amus and the LHβ gene (especially FSHβ (P < 0.05) gene)
in pituitary gland were up-regulated following cLEPR
immunization (Figure 4).
PPARγ mRNA expression
The expression level of PPARγ mRNA were up-regulated
(P < 0.05) in the liver, down-regulated (P < 0.01) in the
abdominal fat tissues, following cLEPR immunization
(Figure 2C and D).
Appetite regulating genes
The expressions of the appetite-stimulating gene in the
hypothalamus, AgRP, orexin were all down-regulatedexpression between Control hens (□, n = 8) and cLEPR
ity was normalized to β-actin) (B) Ratio of p-STAT3 protein/β-actin (the
in liver (D) PPARγ mRNA expression in abdominal fat tissues. Vertical bars
letter are significantly different (a-b: P < 0.05; a-c: P < 0.01).
Figure 3 (See legend on next page.)
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Figure 3 The levels of mRNA expression relative to β-actin of ten genes in thegranulosa (G) and thecal (T) layer of various size ovarian
follicles in Control hens (□, n = 8) and cLEPR Immunized hens (■, n = 8). (A) bcl2 (B) caspase3 (C) fas (D) IGF-I (E) FSHR (F) lepR (G) LHR (H)
StAR (I) CYP17A1 (J) CYP19A1. Fn represents the hierarchical order of follicle size, with the largest follicle designated as F1. Vertical bars represent
the standard errors of the mean. Means not marked by a common letter are significantly different (a-b: P < 0.05; a-c: P < 0.01).
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sion of the anorexic genes, lepR, POMC and MC4R,
however, were significantly up-regulated (Figure 5).
Discussion
Through immunization approach, we have shown that
generating anti-cLEPR ECD antibody caused ovarian fol-
licle atresia by up-regulating the expression of apoptotic
genes, and down-regulating the expression of pro-
development genes, thus caused decreases in egg laying
in chicken hens. These results indicate that manipulating
leptin receptor activities using antibody allows the study
of the regulatory roles of leptin in avian ovarian follicu-
lar development and egg laying.
In this study, the immunization approach was adopted
for producing leptin receptor binding molecules. The anti-
cLEPR antibodies generated appeared to enhance leptin
signal transduction, as was demonstrated by the higher
proportion of phosphorylated STAT3 protein, a key protein
in leptin receptor signal transduction [27-29], in the liver
tissues of cLEPR Immunized hens. This result accords to
our unpublished observation of enhanced leptin receptor
signaling in cLEPR Immunized rats. In addition, the ex-
pression level of PPARγmRNA was down-regulated in adi-
pose tissue in cLEPR-immunized hens. This effect agrees
with the previous reports that administration of leptin
down-regulated PPARγ mRNA expression in the adipose
tissue [39,40]. The up-regulation of PPARγ mRNA expres-
sion in the liver of cLEPR-immunized hens also jibed with
the up-regulation of PPARγ mRNA in cultured porcine
adipose explants [40], which suggested a complex regula-
tion of PPARγ by leptin. Nevertheless, these results dem-
onstrated that anti- cLEPR antibody mimicked the
bioaction of leptin to enhance LEPR signal transduction. InFigure 4 The levels of mRNA expression relative to β-actin in hypotha
Immunized hens (■, n = 8). (A) GnRH-I mRNA expression in hypothalamu
expression in pituitary gland. Vertical bars represent the standard errors of
different (a-b: P < 0.05).the present study, the antigen we prepared composed of
the 200 (101st to 300th) amino acid residues residing in the
N-terminus CK-F3 domain of LEPR [41]. In two other
studies with rats and chicken pullets, immunization against
the sequence from 582nd to 796th amino acid residues of
LEPR, in the F3-F3-F3 domain proximal to the cellular
membrane, also enhanced LEPR signaling, reduced adipose
tissue deposition [unpublished data], reduced live weight,
while increased feed intake [unpublished data]. Results of
our study and the above results indicate that antibodies
bound to LEPR could trigger a signal transduction that
stimulated metabolism. It appears that antibodies directed
against many epitopes of LEPR ECD could trigger a recep-
tor signal transduction. This may be due to the nature of
LEPR, which exists as a dimer [42,43], hence the binding
of any molecule, including antibody, to the dimer would
lead to the formation of a molecule trimer that will cause
receptor signal transduction [41,43].
Leptin receptor that mediates leptin bioactivity is
widely expressed by various tissues [44-46]. Our results
showed that lepR is expressed in both granulosa and
theca layers, with the expression level being higher in
granulosa than in theca tissue. These results were con-
sistent with the results previous reported by Cassy et al.
[47]. In both studies, the lepR expression level decreases
as the follicle enlarges, which might suggest a weaker ex-
pression of lepR in large more mature follicles dimin-
ished the negative regulatory role of leptin [47]. This
form of regulation could be compared to the direct in-
hibition by leptin of gonadotropin and growth factor
stimulated steroid hormone production by cultured rat
granulosa cells [15-17]. Moreover, the expression of
ovarian lepR was up-regulated by ad libitum feeding of
the breeder hens [47], which increased plasma leptinlamus and pituitary gland in Control hens (□, n = 8) and cLEPR
s (B) LHβ mRNA expression in pituitary gland (C) FSHβ mRNA
the mean. Means not marked by a common letter are significantly
Figure 5 mRNA expression levels relative to β-actin of six genes in hypothalamus in Control hens (□, n = 8) and cLEPR Immunized hens
(■, n = 8). A) AgRP mRNA expression (B) orexin mRNA expression (C) NPY mRNA expression (D) POMC mRNA expression (E) MC4R mRNA
expression (F) lepR mRNA expression. Vertical bars represent the standard errors of the mean. Means not marked by a common letter are
significantly different (a-b: P < 0.05; a-c: P < 0.01).
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regulation by immunization against cLEPR ECD. In
many circumstances, cytokine hormones such as GH
and leptin could up-regulate gene expression of its own
receptors [48,49], thus results from our study and those
from previous studies suggest that an up-regulation of
lepR expression in ovarian tissues by ad libitum feeding
and overweight hens was caused also by a molecule di-
rected to lepR, which could be leptin or a molecule
analogous to it, a possibility which is beyond the scope
of the present study.
Both the ad libitum feeding [47] and immunization
caused an up-regulation of lepR which was more pro-
nounced in smaller F4 or F5 follicles. Thus the lepR medi-
ated negative regulation of ovarian follicular development
could be stronger in these small LYFs, or in even smaller
follicles such as SYF and LWF. As expected, upon being
slaughtered on Day 5 after the 4th cLEPR immunization,
severe atresia of SYFs occurred, causing a significant de-
crease to the number of healthy SYFs compared to the
Control hens. Though the number of LYFs and the daily
egg laying rate was only slightly decreased shortly for
5 days, after the 4th cLEPR immunization, atresia of LYFs
was also observed following longer lag by about Day 10
after administration of LEPR (unpublished observations).
Therefore the negative regulation by anti-cLEPR antibody
first appeared in SYFs, and then gradually extended toLYFs as the antibody titers continued to rise following
each administration of antigen, even though the more ma-
ture larger LYFs were more resistant to leptin attenuation.
This effect by anti-cLEPR antibody was also reflected by
the stronger down-regulations of IGF-I and FSHR, but up-
regulation of lepR in smaller than in larger LYFs. The ul-
timate effect is the decrease in egg laying rate in cLEPR
Immunized hens. There also existed a dose dependent ef-
fect of anti-cLEPR antibody titer on reduction of laying
rate between the primary and first booster immunizations.
However laying rate also recovered to the level in the con-
trol hens after the initial drop when the antibody titers
were still high, as was seen prior to the 2rd and 3th booster
immunizations. Further, the higher titer after the 2nd
booster immunization was associated with a less degree of
drop in egg laying rate, compared with the situation after
the 1st booster immunization. It is currently unknown
whether the developing follicles could become refractory
to persistent antibody stimulation, and still developed to
ovulation. The other explanation is that more antibodies
could be generated towards the ‘foreign’ leading peptide
derived from the expression vector, instead of to the ‘self ’
cLEPR domain in the recombinant antigen used. Anti-
bodies to the leading peptide would not bind to cLEPR
and not interfere ovarian follicle development. In this
study, the number of LWFs was not affected by cLEPR
immunization, which may suggest the development and
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assumption was supported by the finding that gonado-
trophin receptor was not expressed in these class of folli-
cles [50,51], and that the leptin effect was mediated
together with gonadotrophin and growth factor regulators
[15-17]. The interruption of egg laying following cLEPR
immunization is comparable to the reduced or even er-
ratic egg laying in ad libitum fed, overweight fast growing
breeder hens [20,21]. In the latter, there was an over-
growth of ovarian follicles, resulting in more than one
SYFs recruited together into the hierarchical development
during each ovulation/oviposition cycle [52,53], which re-
sults in presence of an extraordinary number of LYFs, a
phenomenon akin to the polycystic ovary syndrome in
obese humans [54]. However, despite of the overgrowth,
the LYFs in overweight hens were never as large as those
in restrictedly fed low weight hens, nor as high as steroid
hormone production per follicle [20]. These could indicate
that the largest follicles were not as mature as those of re-
strictedly fed low weight hens, and were not able to se-
crete sufficient steroid hormones to trigger pre-ovulatory
LH surge or could not respond to it, thus leading to a re-
duced egg laying rate [21]. In addition, despite the over-
growth, follicle atresia was often observed especially at
SYFs and small LYFs [53]. This phenomenon again indi-
cated that some metabolic or endocrine factors associated
with high nutrition intake and overweight might induce
cell apoptosis and atresia of the small follicles, similar to
the atresia caused by anti-LEPR antibody.
The anti-LEPR antibody is not able to cross the
blood–brain barrier, therefore cLEPR immunization does
not affect hypothalamic GnRH I and LH gene expres-
sions in pituitary gland. On the contrary, a lack of nega-
tive feedback hormone regulation by oestrogen and
inhibin due to the atresia of SYFs and especially LYFs
was observed. The gene expression of FSH became sig-
nificantly up-regulated in the pituitary gland. These re-
sults indicated that the anti-cLEPR antibody did not
impair hypothalamic-pituitary functionality over repro-
ductive function, and perturbation of the egg laying
should reside at ovarian follicles. The atresia of SYFs and
most probably LYFs was associated with up-regulation
of apoptotic genes caspase3 and fas, and down- regula-
tion of anti-apoptotic genes bcl2 and IGF-I. Except from
the case of fas, the effect of immunization against cLEPR
was more severe, especially for IGF-I, on smaller LYFs,
F4 and F5, and possibly even SYFs, whose expressions
were not analyzed. These results also indicate the atretic
effects of anti-cLEPR antibodies have exerted first to
SYFs and smaller LYFs. Previously, Sirotkin and Gross-
mann had shown that low and moderate levels of leptin
inhibited expressions of apoptotic genes and stimulated
expression of anti-apoptotic gene bcl2 in cultured
chicken ovarian follicle tissue [22]. However the reversewas true when leptin concentration in the culture
medium was further increased [22]. It seemed that the
anti-cLEPR antibody generated following immunization
in this study had mimicked an effect created by high
levels of leptin concentration. This further explains why
only low numbers of SYFs and LYFs undergo atresia in
ad libitum fed overweight hens, whose leptin levels
could be very low and any effect could be mild com-
pared with the high antibody titer in this study. Besides,
low level of leptin stimulated, while high level decreased
the release of progesterone and estradiol by cultured
ovarian follicular tissue [22]. This phenomenon was par-
allelled by the decrease in the expressions of LHR,
FSHR, StAR and CYP17A1 in our study. These results
further indicated that gonadotropin hormone receptor
response and steroid hormone secretion competence
were reduced by the anti-cLEPR antibody affected cells
and follicles.
The rapid growth of LYFs during hierarchical growth
occurs with the deposition of large amount of yolk lipids
and the associated proteins vitellogenin and very low
density lipoprotein [55]. When follicular growth is inter-
rupted, so are the synthesis and secretion of progesterone.
In the mammals, a high circulating concentration of pro-
gesterone during the late pregnancy functions to induce a
state of leptin resistance, so to further enhance food intake
even when a positive energy balance is already reached
[56-58]. In our study, such effect was expressed as a de-
crease in feed intake, when laying drop and follicular atre-
sia occurred after cLEPR immunization, or when the
ovarian follicles stopped secreting progesterone. The
plasma concentrations of HDL in cLEPR Immunized
chickens were significantly lower than those in the Control
chickens. The plasma concentration of LDL in Immunized
cLEPR chickens was significantly higher than in the
Control chickens. These results accord with the results
previous reported by Maki [59]. In addition, blood con-
centrations of glucose and triglycerides in the normal lay-
ing Controls hens were significantly higher than those in
the Immunized hens. These results also suggest a state of
‘leptin resistance’ in the normal laying Control hens. Both
a reduction of hypothalamic expression of Ob-Rb and an
increase in plasma leptin binding protein were implicated
to fulfill the leptin resistance effect of progesterone [58].
The results of this study favored the latter theory: because
the lepR expression in hypothalamus was increased, yet
expressions of the orexigenic genes, Orexin, NPY and
AgRP were down regulated, and those of anorexigenic
genes, MC4R and POMC up-regulated. These results were
in direct contrast to the up-regulation of orexigenic genes,
but down regulation of anorexigenic genes in LEPR im-
munized growing rats [unpubilished data] and also
chicken pullets [unpublished data]. In these growing ani-
mals free from progesterone interference, the anti-cLEPR
Lei et al. Reproductive Biology and Endocrinology 2014, 12:25 Page 11 of 12
http://www.rbej.com/content/12/1/25antibody stimulated metabolism, decreased fat deposition
and even body weight, as well as leptin secretion, thus
stimulated appetite and feed intake. Results from our
study demonstrate the importance of progesterone in
regulation of feed intake in the laying hens.
Conclusions
Immunizing against LEPR ECD in hens generated anti-
bodies that mimic leptin bioactivity by enhancing LEPR
signal transduction. This regulated apoptotic gene expres-
sion in ovarian follicles, down-regulated the expression of
genes supporting follicular development and hormone se-
cretion, leading to follicle atresia and interruption of egg
laying. Inhibition of progesterone secretion due to failure
of follicle development also lowered feed intake. The re-
sults of this study demonstrate immunization against
LEPR ECD may be utilized as a tool for studying bio-
functions of chicken LEPR.
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